| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q2G1W2 (PCKA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Phosphoenolpyruvate carboxykinase (ATP); | |
| Q2FXU2 (DTD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | D-aminoacyl-tRNA deacylase; Gly-tRNA(Ala) deacylase; | |
| Q2FY49 (ARGR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Arginine repressor; | |
| Q2G2K8 (UREE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Urease accessory protein UreE; | |
| Q2G2T3 (RL9_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein bL9; 50S ribosomal protein L9; | |
| Q2FVE7 (CNTA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Metal-staphylopine-binding protein CntA; | |
| Q2FZP4 (RF3_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peptide chain release factor 3; | |
| Q2FUW4 (ASP2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Accessory Sec system protein Asp2; Accessory secretory protein Asp2; | |
| Q2G0P8 (CTSR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcriptional regulator CtsR; | |
| Q2G1E0 (HPTS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Sensor protein kinase HptS; | |
| Q2G0B6 (Y689_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0178 protein SAOUHSC_00689; | |
| Q2FXT2 (Y1752_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0735 ACT domain-containing protein SAOUHSC_01752; | |
| Q2FWJ6 (SPRTL_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Protein SprT-like; | |
| Q2G247 (Y1855_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0478 protein SAOUHSC_01855; | |
| Q2FV60 (CRTN_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 4,4'-diapophytoene desaturase (4,4'-diaponeurosporene-forming); Dehydrosqualene desaturase; | |
| Q2FWE8 (ATPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | ATP synthase subunit alpha; ATP synthase F1 sector subunit alpha; F-ATPase subunit alpha; | |
| Q2G1C2 (TARK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Teichoic acid ribitol-phosphate polymerase TarK; Poly(ribitol phosphate) polymerase TarK; Ribitol-phosphate polymerase TarK; Tar polymerase TarK; | |
| Q2FXG2 (RISB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 6,7-dimethyl-8-ribityllumazine synthase; | |
| Q2FWV5 (CHIPS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Chemotaxis inhibitory protein; CHIPS; | |
| Q2FYG7 (NDK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Nucleoside diphosphate kinase; Nucleoside-2-P kinase; | |
| Q2FWD1 (PYRG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | CTP synthase; Cytidine 5'-triphosphate synthase; Cytidine triphosphate synthetase; UTP--ammonia ligase; | |
| Q2G2F8 (ATPF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | ATP synthase subunit b; ATP synthase F(0) sector subunit b; ATPase subunit I; F-type ATPase subunit b; | |
| O05204 (AHPF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Alkyl hydroperoxide reductase subunit F; | |
| Q2FXW7 (GREA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcription elongation factor GreA; Transcript cleavage factor GreA; | |
| Q2FWK3 (LEU1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-isopropylmalate synthase; Alpha-IPM synthase; Alpha-isopropylmalate synthase; | |
| Q2G212 (MNHD2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative antiporter subunit mnhD2; Mrp complex subunit D2; Putative NADH-ubiquinone oxidoreductase subunit mnhD2; | |
| Q2FYZ5 (GLPK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycerol kinase; ATP:glycerol 3-phosphotransferase; Glycerokinase; | |
| Q2FVH6 (FLP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Protein flp; FmtA-like protein; | |
| Q2FW84 (MDEP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Multidrug resistance efflux pump SepA; Antiseptic resistance protein SepA; Staphylococcal efflux pump A; | |
| Q2FWY7 (PUTP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Sodium/proline symporter; Proline permease; | |
| Q2FVX9 (MOAC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Cyclic pyranopterin monophosphate synthase; Molybdenum cofactor biosynthesis protein C; | |
| Q2FYU7 (CATA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Catalase; | |
| Q2FW66 (ASP23_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Alkaline shock protein 23; | |
| Q2FZP9 (Y951_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative phosphoesterase SAOUHSC_00951; | |
| P0A084 (MSRA1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peptide methionine sulfoxide reductase MsrA 1; Peptide-methionine (S)-S-oxide reductase 1; | |
| Q2G1J0 (ALDA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative aldehyde dehydrogenase AldA; | |
| Q2G2P5 (NIKA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Nickel-binding protein NikA; SaNikA; | |
| Q2FX77 (LYTO_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable autolysin LytO; | |
| Q2FXU0 (APT_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Adenine phosphoribosyltransferase; | |
| Q2FZI6 (PUR9_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Bifunctional purine biosynthesis protein PurH; Phosphoribosylaminoimidazolecarboxamide formyltransferase; 2.1.2.3; AICAR transformylase; IMP cyclohydrolase; 3.5.4.10; ATIC; IMP synthase; Inosinicase; | |
| Q2FZP6 (MURE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--L-lysine ligase; L-lysine-adding enzyme; UDP-MurNAc-L-Ala-D-Glu:L-Lys ligase; UDP-MurNAc-tripeptide synthetase; UDP-N-acetylmuramyl-tripeptide synthetase; | |
| Q2FWZ8 (FTN_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Bacterial non-heme ferritin; | |
| Q2G2V3 (MENE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-succinylbenzoate--CoA ligase; o-succinylbenzoyl-CoA synthetase; | |
| Q2FXL6 (Y1819_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative universal stress protein SAOUHSC_01819; | |
| Q2FW23 (RS5_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Small ribosomal subunit protein uS5; 30S ribosomal protein S5; | |
| Q2G081 (QUEF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | NADPH-dependent 7-cyano-7-deazaguanine reductase; 7-cyano-7-carbaguanine reductase; NADPH-dependent nitrile oxidoreductase; PreQ(0) reductase; | |
| Q2G0N9 (RL10_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein uL10; 50S ribosomal protein L10; | |
| Q9RFJ6 (ROT_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | HTH-type transcriptional regulator rot; Repressor of toxins; | |
| Q2FV56 (CRTO_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycosyl-4,4'-diaponeurosporenoate acyltransferase; | |
| Q2FZW6 (DLTA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | D-alanine--D-alanyl carrier protein ligase; D-alanine--poly(phosphoribitol) ligase subunit 1; D-alanine-activating enzyme; |
Staphylococcus aureus is a Gram-positive coccal bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections such as abscesses, respiratory infections such as sinusitis, and food poisoning.
An estimated 20% of the human population are long-term carriers of S. aureus. It is one of the five most common causes of hospital-acquired infections and is often the cause of postsurgical wound infections. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. There are currently (2016) no dedicated antibiotics against drug-resistant S. aureus available.
The genome of S. aureus was first sequenced in 2006.
From left to right: i) The number of proteins in the reference proteome of Staphylococcus aureus, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Staphylococcus aureus for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Staphylococcus aureus, please visit UniProtKB.
You can easily download the latest protein sequences for Staphylococcus aureus proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_01 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 2,889 | 2,404 | 3,823 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Staphylococcus aureus reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Staphylococcus aureus proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 13-mer | 14-mer | 24-mer | 25-mer | 40-mer | 60-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,416 | 977 | 81 | 204 | 6 | 77 | 6 | 15 | 2 | 8 | 13 | 3 | 5 | 7 | 1 | 1 | 1 |
